Nagashima M
Department of Cardiovascular Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Hokkaido Igaku Zasshi. 1994 Jul;69(4):940-52.
The present study was undertaken to determine alpha 1-adrenoceptor subtype involved in the inotropic, electrophysiological and phosphoinositide responses to myocardial alpha 1-adrenoceptor stimulation. Phenylephrine in the presence of the beta-adrenoceptor antagonist, propranolol, elicited a positive inotropic effect in a concentration-dependent manner in both rat and rabbit papillary muscles. In rat papillary muscle, the positive inotropic effect of phenylephrine was antagonized by the alpha 1A-selective antagonist, WB4101, but not affected by the alpha 1B-antagonist, chloroethylclonidine (CEC). On the other hand, the positive inotropic effect in rabbit papillary muscle was antagonized by both WB4101 and CEC. The inotropic response of rat papillary muscle to phenylephrine was composed of a negative inotropic phase and a positive inotropic phase, both of which were blocked only by WB4101. In both rat and rabbit papillary muscles, phenylephrine caused prolongation of action potential duration. WB4101, but not CEC, significantly suppressed the APD prolongation. Only in rat papillary muscle, phenylephrine exerted hyperpolarization of resting membrane potential, an effect which was also eliminated by WB4101. Furthermore, stimulation of phosphoinositide hydrolysis induced by phenylephrine (evaluated by [3H] inositol monophosphate accumulation) was inhibited by WB4101 in a concentration-dependent fashion, but the inhibitory effect on the response to phenylephrine was seen with CEC only at a higher concentration. From these results, it was concluded that both myocardial alpha 1A- and alpha 1B-adrenoceptor subtypes are able to mediate a positive inotropic effect, and that the alpha 1A-adrenoceptor-mediated positive inotropic effect is exclusively dependent on the prolongation of action potential duration, while the alpha 1B-adrenoceptor-mediated one appear to be due to a mechanism other than electrophysiological changes. In addition, based on the previous respects that the phosphatidyl-inositol hydrolytic products do not contribute to the alpha 1-adrenoceptor-mediated electrophysiological effects, the present data suggest that the coupling of alpha 1A-adrenoceptors to phosphatidylinositol hydrolysis may be independent of the positive inotropism.
本研究旨在确定参与心肌α1肾上腺素能受体刺激所引发的变力性、电生理和磷酸肌醇反应的α1肾上腺素能受体亚型。在β肾上腺素能受体拮抗剂普萘洛尔存在的情况下,去氧肾上腺素在大鼠和家兔乳头肌中均以浓度依赖性方式引发正性变力作用。在大鼠乳头肌中,去氧肾上腺素的正性变力作用被α1A选择性拮抗剂WB4101拮抗,但不受α1B拮抗剂氯乙可乐定(CEC)影响。另一方面,家兔乳头肌中的正性变力作用被WB4101和CEC均拮抗。大鼠乳头肌对去氧肾上腺素的变力反应由负性变力相和正性变力相组成,二者均仅被WB4101阻断。在大鼠和家兔乳头肌中,去氧肾上腺素均导致动作电位时程延长。WB4101而非CEC可显著抑制动作电位时程的延长。仅在大鼠乳头肌中,去氧肾上腺素使静息膜电位超极化,此效应也被WB4101消除。此外,WB4101以浓度依赖性方式抑制去氧肾上腺素诱导的磷酸肌醇水解(通过[3H]肌醇一磷酸积累评估),但CEC仅在较高浓度时才对去氧肾上腺素反应产生抑制作用。从这些结果得出结论,心肌α1A和α1B肾上腺素能受体亚型均能够介导正性变力作用,且αIA肾上腺素能受体介导的正性变力作用完全依赖于动作电位时程的延长,而α1B肾上腺素能受体介导的正性变力作用似乎是由电生理变化以外的机制所致。此外,基于先前磷脂酰肌醇水解产物对α1肾上腺素能受体介导的电生理效应无贡献这一观点,目前的数据表明α1A肾上腺素能受体与磷脂酰肌醇水解的偶联可能独立于正性变力作用。